SKIN ATLAS · ACTIVE INGREDIENT · 4 MIN. READ

Hypochlorous Acid and Neuro-Soothing: Antimicrobial Balance and Neurosensory Skin Calming

Hypochlorous acid (HOCl) is an endogenous, weak oxyacid produced by neutrophilic granulocytes as part of the innate immune response. In modern cosmetology, it is used as a topical active principle for antimicrobial and anti-inflammatory purposes. In formulation science, the term "neuro-soothing" refers to the targeted reduction of neurogenic inflammatory reactions in the skin — i.e., those sensory overstimulation processes where nerve fibers in the upper dermis release inflammatory mediators. The combination of both approaches addresses a bimodally disturbed skin physiology: microbial imbalance on the one hand and an overactive cutaneous neuro-axis on the other.

Term and Origin

The term Hypochlorous Acid (HOCl) is derived from the Greek hypo (under) and the Latin chlorum (chlorine) — it is the weakest of the chlorine oxyacids. It was first chemically described in the 19th century; however, its biological significance within the oxidative burst reaction of immune cells was not systematically researched until the late 20th century. In dermatology, HOCl gained clinical attention starting in the 2000s when electrolytically stabilized formulations were developed, allowing for topical application without skin irritation. The WHO classification of HOCl as a biocidal active ingredient and the increasing interest in skin microbiome-friendly alternatives to traditional antiseptics promoted its inclusion in the cosmetic formulation canon.

The concept of neuro-soothing — often referred to as neuro-calming or neuro-soothing in English — is of more recent origin and stems from the intersection of neurobiology and dermatology, the emerging field of neuro-dermatology. It describes active ingredients or formulation strategies that specifically act on cutaneous nerve fibers — particularly on the neuropeptide release of Substance P and CGRP (Calcitonin Gene-Related Peptide), which drive neurogenic inflammation. The concept is rooted in the understanding that chronically irritated skin cannot solely be explained by microbial or barrier-related disturbances but often exhibits an overactivated cutaneous neuro-axis.

The connection between both concepts is not merely a marketing construct: Neurogenic inflammation creates a pro-inflammatory milieu that promotes microbial imbalances — conversely, microbially released toxins like staphylococcal exotoxins directly activate sensory nerve fibers. HOCl addresses both sides of this loop with a biochemically elegant mechanism.

Characteristics & Mechanism of Action

HOCl acts on a cellular level primarily through oxidative chlorination: It reacts with thiol-containing proteins and lipopolysaccharides of bacterial cell walls, destabilizes their membrane integrity, and inhibits protein synthesis in pathogenic germs — including Staphylococcus aureus, which plays a key pathogenetic role in eczema, acne, and dermatitis. Unlike conventional antiseptics such as benzoyl peroxide or chlorhexidine, HOCl shows a selective effect at physiological concentrations (0.005–0.02%): Commensal skin bacteria of the healthy microbiome are significantly less affected than pathogenic strains, as they possess more efficient antioxidant defense mechanisms.

The neuro-soothing mechanism of action of HOCl is indirect: By reducing pro-inflammatory cytokines — particularly IL-1β, IL-6, and TNF-α — the neurogenic inflammatory milieu is interrupted. Inflammation activates TRPV1 and TRPA1 channels on sensory C-fibers, leading to neuropeptide release and making the inflammatory cascade self-sustaining. HOCl interrupts this cycle by lowering the initial cytokine load before sensory nerve fibers are activated. Additionally, in-vitro studies suggest that HOCl inhibits mast cell degranulation — another trigger point for neurogenic hypersensitivity reactions of the skin. For sensitive skin with a reactive component, this dual mechanism of action is particularly relevant.

From a formulation perspective, HOCl presents a challenge: The acid is thermodynamically unstable and prone to disproportionation into chlorine and water. Modern electrolytic production processes — the electrolysis of dilute NaCl solutions — enable stable, buffered formulations in the pH range of 4–6, which also corresponds to the skin's natural acid mantle. This makes HOCl tolerable and non-irritating, provided the concentration and pH are correctly calibrated.

Skincare Approach

In cosmetic practice, HOCl is typically formulated as a light spray, essence, or toner solution — textures that allow for large-area, even application without mechanical friction. Friction itself can trigger neurogenic stimuli; therefore, gentle spraying or dabbing is recommended, not rubbing. HOCl-containing products are usually applied after cleansing and before serum-based active ingredients — in a routine that precedes Double Cleansing. As a preparation of the skin for subsequent active ingredients, HOCl can optimize penetration conditions by reducing the microbial load on the skin surface and lowering the inflammation level.

When combining with other active ingredients, clear compatibility limits apply: HOCl should not be used simultaneously with highly concentrated AHA or BHA products, as the cumulative acid load can temporarily destabilize the barrier. In contrast, HOCl works synergistically with barrier-supporting active ingredients such as ceramides and beta-glucans, which restore the barrier environment weakened after the antimicrobial phase. For skin with a neurogenic hypersensitivity component, combination with Ectoin is recommended — an extremolyte that also exhibits anti-inflammatory and membrane-stabilizing properties, as extensively explained in the article on Ectoin.

Within the framework of chronobiologically informed routines, as described by the concept of chronobiology in skincare, HOCl is preferably suitable for morning application: The cutaneous immune system shows increased activity in the morning, and the antimicrobial preparation of the skin before daily protection (sun protection, antioxidants) corresponds to the physiological rhythm of skin defense. The Porcelain Skin Serum or the Blue Crystal Drops can be well integrated as subsequent layers in this morning routine.

Realistic Expectations

HOCl is not an acute therapeutic agent in the medical sense, but rather a modulating active ingredient whose effects are cumulative. With consistent daily application, clinical observations show initial improvements in skin tone — less redness, reduced sensitivity to external stimuli — after about two to four weeks. A measurable reduction in inflammation-associated lesions in mild acne or seborrheic irritation is reported in the literature after four to eight weeks of regular use.

Individual variance is considerable: Skin biomes differ greatly between individuals, and the neurogenic component of irritated skin depends on genetic, hormonal, and environmental factors. Those who use HOCl for severe dermatitis or chronic eczema should do so in consultation with a dermatologist, as therapeutic interventions may supplement or replace cosmetic application in such cases. As a preventive component of a soothing routine for reactive but clinically unremarkable skin, HOCl is safe and well-tolerated — provided the formulation is electrolytically produced, pH-stabilized, and free of irritating excipients.

Frequently Asked Questions

Is hypochlorous acid the same as chlorine water or bleach?

No. Commercial bleaches like sodium hypochlorite (NaOCl) are strongly alkaline and formulated in significantly higher concentrations — they are not suitable for direct skin contact. HOCl, on the other hand, exists in physiological pH ranges, is the weaker acid of hypochlorite chemistry, and corresponds to what white blood cells produce themselves. Cosmetically used HOCl is produced electrolytically from saline solution and, in its pure form, is not comparable to industrial bleaches.

Can HOCl permanently damage the skin microbiome?

At concentrations relevant for cosmetics (below 0.02%), the potential for damage to commensal bacteria like Staphylococcus epidermidis is low. Studies show that HOCl at physiological pH is more selective against pathogenic germs than against protective germs. Long-term data from dermatological use in patients with atopic dermatitis support this assessment. Nevertheless, HOCl should not be used multiple times daily or as the sole skincare solution; integration into a balanced routine with moisturizers and barrier-supporting active ingredients is recommended.

For which skin types is HOCl suitable?

HOCl is particularly suitable for reactive, reddened, and microbially compromised skin — i.e., for combinations of sensitive skin, oily skin prone to comedones, and for skin with a neurogenic hypersensitivity component. For very dehydrated skin without an inflammatory component, the benefit is lower; other active ingredients are prioritized there. People with healthy, unremarkable skin can use HOCl preventively, but should check the formulation context: A fragrance-free, alcohol-free product is a prerequisite for fragrance-free tolerability in sensually reactive skin.

Conclusion

Hypochlorous acid is one of the biochemically most fascinating active ingredients in modern evidence-based cosmetology — not despite, but because of its endogenous nature. As a topical agent, it combines antimicrobial precision with anti-inflammatory depth of action, thus addressing two pathophysiologically closely linked disturbances of irritated skin: microbial imbalance and neurogenic hypersensitivity. In correct formulation, it is safe, well-tolerated, and compatible with a wide range of skin conditions. Integration into a thoughtful routine — combined with barrier-forming agents like ceramides, moisture reservoirs, and chronobiologically informed application times — maximizes its potential. For all those whose skin chronically overreacts to external and internal stimuli, HOCl represents a scientifically sound approach that operates beyond classic soothing care: not sedating, but regulating — on both molecular and neurosensory levels.

1. Bogdan Allemann I. & Baumann L. (2008). Hyaluronic acid gel (Juvéderm) preparations in the treatment of facial wrinkles and folds. Clinical Interventions in Aging, 3(4), 629–634.
2. Wang L., Bassiri M., Najafi R. et al. (2007). Hypochlorous acid as a potential wound care agent. Journal of Burns and Wounds, 6, e5.
3. Levin J. & Maibach H. (2002). Topical corticosteroid-induced adrenocortical insufficiency: Clinical implications. American Journal of Clinical Dermatology, 3(3), 141–147.
4. Draelos Z.D. (2011). The science behind skin care: Cleansers. Journal of Cosmetic Dermatology, 17(1), 17–22.
5. Schaper-Gerhardt K., Mrowietz U. & Christophers E. (2019). Neurogene Entzündung bei Hauterkrankungen — Mechanismen und therapeutische Implikationen. JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 17(6), 601–612.
6. Severing A.L., Rembe J.D., Koester V. & Stuermer E.K. (2019). Safety and efficacy profiles of different commercial formulations of hypochlorous acid for the use in wound management. Wound Repair and Regeneration, 27(2), 159–167.